Canada markets closed
  • S&P/TSX

    19,228.03
    -0.87 (-0.00%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.00 (+0.89%)
     
  • CAD/USD

    0.7974
    +0.0013 (+0.17%)
     
  • CRUDE OIL

    59.34
    +0.02 (+0.03%)
     
  • BTC-CAD

    74,881.88
    -616.67 (-0.82%)
     
  • CMC Crypto 200

    1,235.89
    +8.35 (+0.68%)
     
  • GOLD FUTURES

    1,744.10
    -0.70 (-0.04%)
     
  • RUSSELL 2000

    2,243.47
    +0.87 (+0.04%)
     
  • 10-Yr Bond

    1.6660
    +0.0340 (+2.08%)
     
  • NASDAQ

    13,900.19
    +70.89 (+0.51%)
     
  • VOLATILITY

    16.69
    -0.26 (-1.53%)
     
  • FTSE

    6,915.75
    -26.47 (-0.38%)
     
  • NIKKEI 225

    29,768.06
    +59.06 (+0.20%)
     
  • CAD/EUR

    0.6699
    +0.0022 (+0.33%)
     

Coherus Management to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
Coherus BioSciences, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March.

  • 41st Annual Cowen Healthcare Conference on Monday, March 1 at 4 p.m. ET

  • Barclays Global Healthcare Conference on Tuesday, March 9 at 1:15 p.m. ET

The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.

For additional information, please visit www.coherus.com.

Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152